机构:[1]Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, and Collaborative Innovation Center of Cancer Medicine, Guangzhou, China临床科室其他部门内科华南肿瘤学国家重点实验室中山大学肿瘤防治中心[2]Department of Medical Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China其他科室肿瘤科中山大学附属第一医院[3]Department of Medical Oncology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China[4]Department of Radiotherapy, Sun Yat-sen University Cancer Center, Guangzhou, China临床科室放疗科中山大学肿瘤防治中心[5]Department of Medical Oncology, He Nan Cancer Hospital, Zhengzhou, China内科第一医学部肿瘤内科河南省肿瘤医院[6]Department of Medical Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China[7]Department of Medical Oncology, Guangxi Cancer Hospital, Nanning, China[8]Department of Medical Oncology, Hunan Cancer Hospital, Changsha, China[9]Department of Medical Oncology, Kiang Wu Hospital, Macau, China[10]Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China临床科室病理科中山大学肿瘤防治中心[11]Department of Medical Oncology, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China[12]Department of Epidemiology, Sun Yat-sen University Cancer Center, Guangzhou, China中山大学肿瘤防治中心
Guangdong Science and Technology Department [2017B020227002]
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类|1 区医学
小类|2 区血液学
最新[2023]版:
大类|1 区医学
小类|2 区血液学
第一作者:
第一作者机构:[1]Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, and Collaborative Innovation Center of Cancer Medicine, Guangzhou, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, and Collaborative Innovation Center of Cancer Medicine, Guangzhou, China[*1]Department of Medical Oncology, Sun Yat-Sen University Cancer Center, 651 Dongfeng Rd E, Guangzhou, China.
推荐引用方式(GB/T 7714):
Huangming Hong,He Huang,Xiaojie Fang,et al.A prognostic index for nasal-type early-stage extranodal natural killer/T-cell lymphoma: A multicenter study[J].AMERICAN JOURNAL OF HEMATOLOGY.2019,94(5):E122-E124.doi:10.1002/ajh.25426.
APA:
Huangming Hong,He Huang,Xiaojie Fang,Zhao Wang,Sheng Ye...&Tongyu Lin.(2019).A prognostic index for nasal-type early-stage extranodal natural killer/T-cell lymphoma: A multicenter study.AMERICAN JOURNAL OF HEMATOLOGY,94,(5)
MLA:
Huangming Hong,et al."A prognostic index for nasal-type early-stage extranodal natural killer/T-cell lymphoma: A multicenter study".AMERICAN JOURNAL OF HEMATOLOGY 94..5(2019):E122-E124